Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 1
2017 1
2018 1
2019 4
2020 3
2021 4
2022 5
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

19 results

Results by year

Filters applied: . Clear all
Page 1
Effects of Standard-Dose Prophylactic, High-Dose Prophylactic, and Therapeutic Anticoagulation in Patients With Hypoxemic COVID-19 Pneumonia: The ANTICOVID Randomized Clinical Trial.
Labbé V, Contou D, Heming N, Megarbane B, Razazi K, Boissier F, Ait-Oufella H, Turpin M, Carreira S, Robert A, Monchi M, Souweine B, Preau S, Doyen D, Vivier E, Zucman N, Dres M, Fejjal M, Noel-Savina E, Bachir M, Jaffal K, Timsit JF, Picos SA, Mariotte E, Martis N, Juguet W, Melica G, Rondeau P, Audureau E, Mekontso Dessap A; ANTICOVID Investigators. Labbé V, et al. JAMA Intern Med. 2023 Jun 1;183(6):520-531. doi: 10.1001/jamainternmed.2023.0456. JAMA Intern Med. 2023. PMID: 36946232 Free PMC article.
Avdoralimab (Anti-C5aR1 mAb) Versus Placebo in Patients With Severe COVID-19: Results From a Randomized Controlled Trial (FOR COVID Elimination [FORCE]).
Carvelli J, Meziani F, Dellamonica J, Cordier PY, Allardet-Servent J, Fraisse M, Velly L, Barbar SD, Lehingue S, Guervilly C, Desgrouas M, Camou F, Piperoglou C, Vely F, Demaria O, Karakunnel J, Fares J, Batista L, Rotolo F, Viotti J, Boyer-Chammard A, Lacombe K, Le Dault E, Carles M, Schleinitz N, Vivier E; FOR COVID Elimination (FORCE) Study Group. Carvelli J, et al. Crit Care Med. 2022 Dec 1;50(12):1788-1798. doi: 10.1097/CCM.0000000000005683. Epub 2022 Oct 10. Crit Care Med. 2022. PMID: 36218354 Free PMC article. Clinical Trial.
Tocilizumab-induced hypofibrinogenemia: A report of 7 cases.
Martis N, Chirio D, Queyrel-Moranne V, Zenut MC, Rocher F, Fuzibet JG. Martis N, et al. Among authors: chirio d. Joint Bone Spine. 2017 May;84(3):369-370. doi: 10.1016/j.jbspin.2016.04.008. Epub 2016 Jun 17. Joint Bone Spine. 2017. PMID: 27324602 No abstract available.
Hepatitis Rebound after Infection with Yellow Fever Virus.
Denis B, Chirio D, Ponscarme D, Brichler S, Colin de Verdière N, Simon F, Molina JM. Denis B, et al. Among authors: chirio d. Emerg Infect Dis. 2019 Jun;25(6):1248-1249. doi: 10.3201/eid2506.190069. Epub 2019 Jun 17. Emerg Infect Dis. 2019. PMID: 30870138 Free PMC article.
What about using sniffin' sticks 12 items test to screen post-COVID-19 olfactory disorders?
Vandersteen C, Payne M, Dumas LÉ, Plonka A, D'Andréa G, Chirio D, Demonchy É, Risso K, Robert P, Fernandez X, Askenazy-Gittard F, Savoldelli C, Guevara N, Castillo L, Manera V, Gros A. Vandersteen C, et al. Among authors: chirio d. Eur Arch Otorhinolaryngol. 2022 Jul;279(7):3477-3484. doi: 10.1007/s00405-021-07148-y. Epub 2021 Oct 30. Eur Arch Otorhinolaryngol. 2022. PMID: 34716806 Free PMC article.
Olfactory Training in Post-COVID-19 Persistent Olfactory Disorders: Value Normalization for Threshold but Not Identification.
Vandersteen C, Payne M, Dumas LÉ, Cancian É, Plonka A, D'Andréa G, Chirio D, Demonchy É, Risso K, Askenazy-Gittard F, Savoldelli C, Guevara N, Robert P, Castillo L, Manera V, Gros A. Vandersteen C, et al. Among authors: chirio d. J Clin Med. 2022 Jun 8;11(12):3275. doi: 10.3390/jcm11123275. J Clin Med. 2022. PMID: 35743346 Free PMC article.
A case of infective endocarditis caused by Arthrobacter woluwensis.
Durand C, Kouchit Y, Prots L, Degand N, Dellamonica P, Demonchy E, Chirio D. Durand C, et al. Among authors: chirio d. Eur J Clin Microbiol Infect Dis. 2021 Jun;40(6):1329-1331. doi: 10.1007/s10096-021-04154-0. Epub 2021 Jan 11. Eur J Clin Microbiol Infect Dis. 2021. PMID: 33432493
Heterogeneous NLRP3 inflammasome signature in circulating myeloid cells as a biomarker of COVID-19 severity.
Courjon J, Dufies O, Robert A, Bailly L, Torre C, Chirio D, Contenti J, Vitale S, Loubatier C, Doye A, Pomares-Estran C, Gonfrier G, Lotte R, Munro P, Visvikis O, Dellamonica J, Giordanengo V, Carles M, Yvan-Charvet L, Ivanov S, Auberger P, Jacquel A, Boyer L. Courjon J, et al. Among authors: chirio d. Blood Adv. 2021 Mar 9;5(5):1523-1534. doi: 10.1182/bloodadvances.2020003918. Blood Adv. 2021. PMID: 33683342 Free PMC article.
19 results